Table 2. Comparison of GSTT1 and GSTM1 null genotypes according to gender distribution in patients and controls. A p<0.05 was considered statistically significant.
| Genotype | Group | Controls (n=162) | Patients (n=165) | p (χ2) |
|---|---|---|---|---|
| T0 |
Total |
16 (10%) |
39 (24%) |
<0.05 (11.06) |
| T1 |
|
146 (90%) |
126 (76%) |
|
| M0 |
Total |
58 (36%) |
85 (52%) |
<0.05 (8.20) |
| M1 |
|
104 (64%) |
80 (48%) |
|
| Genotype |
|
Controls (n=77) |
Patients (n=77) |
p (χ2) |
| T0 |
Females |
1 (1%) |
20 (26%) |
<0.05 (19.90) |
| T1 |
|
76 (99%) |
57 (74%) |
|
| M0 |
Females |
16(21%) |
42(55%) |
<0.05 (18.70) |
| M1 |
|
61(79%) |
35(45%) |
|
| Genotype |
|
Controls (n=85) |
Patients (n=88) |
p (χ2) |
| T0 |
Males |
15(18%) |
19(22%) |
>0.05(0.43) |
| T1 |
|
70(82%) |
69(78%) |
|
| M0 |
Males |
42(49%) |
43(49%) |
>0.05(0.01) |
| M1 | 43(51%) | 45(51%) |